Pharma Two B reports positive Phase III Parkinson's drug tri

The results found similar efficacy to existing treatments but with reduced side-effects such as less daytime drowsiness.

Related Keywords

Rehovot , Hamerkaz , Israel , Israeli , Teva Parkinson , Ehud Marom , Sheila Oren , Mapi Pharma , Pharma Twob Ltd , Israel Biotech Fund Photo , Biotech Fund Photo , Yoram Sela , Unified Parkinson , Disease Rating , Epworth Sleepiness ,